Citigroup, Inc. – Consensus Indicates Potential 22.2% Upside

DirectorsTalk Interviews

Citigroup, Inc. with ticker code (C) have now 22 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The range between the high target price and low target price is between 95 and 46 with the average target price sitting at 60.99. Now with the previous closing price of 49.9 this would indicate that there is a potential upside of 22.2%. The 50 day moving average now sits at 50.37 while the 200 day moving average is 55.37. The company has a market capitalisation of $98,133m. Company Website: https://www.citigroup.com

The potential market cap would be $119,943m based on the market concensus.

Citigroup Inc., a diversified financial services holding company, provides various financial products and services to consumers, corporations, governments, and institutions in North America, Latin America, Asia, Europe, the Middle East, and Africa. The company operates in two segments, Global Consumer Banking (GCB) and Institutional Clients Group (ICG). The GCB segment offers traditional banking services to retail customers through retail banking, Citi-branded cards, and Citi retail services. It also provides various banking, credit card, lending, and investment services through a network of local branches, offices, and electronic delivery systems. The ICG segment offers wholesale banking products and services, including fixed income and equity sales and trading, foreign exchange, prime brokerage, derivative, equity and fixed income research, corporate lending, investment banking and advisory, private banking, cash management, trade finance, and securities services to corporate, institutional, public sector, and high-net-worth clients. As of December 31, 2020, it operated 2,303 branches primarily in the United States, Mexico, and Asia. Citigroup Inc. was founded in 1812 and is headquartered in New York, New York.

Share on:

Latest Company News

Genflow Biosciences reports continued SIRT6 progress in first half of 2026

Genflow Biosciences reported positive interim and three-month follow-up results from its SLAB canine trial, expanded animal health partnerships, secured a fully funded LNP collaboration with Acuitas Therapeutics and strengthened its SIRT6 patent portfolio.

Real Estate Credit Investments (RECI) FY’26 results: High yield, clear path to dividend cover

Real Estate Credit Investments maintained its 3p quarterly dividend, offering a 10.3% yield, while outlining routes to restore dividend cover. Credit performance remains strong, leverage is conservative and the shares continue to trade at a substantial discount to NAV.

RM Assessment targets expanding demand for digital exams

RM Assessment is positioned to benefit as schools and awarding bodies adopt more digital and hybrid examination systems.

Drax takes control of Aldi’s UK EV charging network

Drax will operate and expand around 1,200 electric vehicle chargers across Aldi’s UK store network.

Energy strength and resilient trading updates support the FTSE 100

Higher oil prices and resilient company updates supported a steadier outlook for the FTSE 100.

AI leadership gives emerging markets a stronger strategic position

Emerging markets are gaining a more important role in the global artificial intelligence economy, led by major Asian semiconductor companies with strong positions in advanced computing infrastructure.

    Search